Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

URBAN ARCH (3/5) Uganda Cohort TB Preventive Therapy for HIV-infected Alcohol Users in Uganda: an Evaluation of Safety Tolerability and Adherence

NCT03302299 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT03302299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03302299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
URBAN ARCH (3/5) Uganda Cohort TB Preventive Therapy for HIV-infected Alcohol Users in Uganda: an Evaluation of Safety Tolerability and Adherence
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Completed
Start date
April 7, 2017
Completion date
April 1, 2021
Enrollment
302 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol abuse, hiv/aids, tuberculosis